SCYNEXIS Inc
SCYX0.702USD
+0.021+3.11%
交易中 （美東）報價延遲15分鐘
27.40M總市值
虧損本益比TTM
關於 SCYNEXIS Inc 公司
SCYNEXIS, Inc. 是一家生物技術公司。該公司是治療和預防難治性感染和耐藥性感染的先驅藥物。該公司開發了抗真菌平臺 fungerps，這是一種新型抗真菌劑，稱爲三萜類化合物，是結構獨特的葡聚糖合酶抑制劑，在體外和體內均表現出對抗一系列人類真菌病原體的活性，例如念珠菌屬和麴黴菌屬（包括耐多藥菌株）以及肺孢子菌、球孢子菌、組織胞漿菌和芽生菌屬以及常見的毛黴菌種。Ibrexafungerp 是此類新型抗真菌劑的首個代表，此外還有 fungerp 家族的其他資產，包括 SCY-247，目前正處於臨牀前開發階段。美國食品藥品監督管理局批准 BREXAFEMME 用於治療外陰陰道念珠菌病（也稱爲陰道酵母菌感染）患者，並降低複發性外陰陰道念珠菌病的發病率。
公司簡介
公司代碼SCYX
公司名稱SCYNEXIS Inc
上市日期May 02, 2014
CEODr. David Angulo, M.D.
員工數量28
證券類型Ordinary Share
年結日May 02
公司地址1 Evertrust Plaza
城市JERSEY CITY
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編07302-6548
電話12018845485
網址https://www.scynexis.com/
公司代碼SCYX
上市日期May 02, 2014
CEODr. David Angulo, M.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Ivor Macleod, CPA
Mr. Ivor Macleod, CPA
Chief Financial Officer
Chief Financial Officer
71.40K
-30.69%
Mr. Guy Macdonald
Mr. Guy Macdonald
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
55.00K
+71.88%
Mr. Armando Anido
Mr. Armando Anido
Independent Director
Independent Director
48.00K
+92.00%
Dr. Steven C. Gilman, Ph.D.
Dr. Steven C. Gilman, Ph.D.
Independent Director
Independent Director
47.00K
+95.83%
Dr. Ann F. Hanham, Ph.D.
Dr. Ann F. Hanham, Ph.D.
Independent Director
Independent Director
46.62K
+97.37%
Mr. David C. Hastings
Mr. David C. Hastings
Independent Director
Independent Director
46.18K
+99.21%
Mr. Scott A. Sukenick, J.D.
Mr. Scott A. Sukenick, J.D.
Chief Legal Officer, General Counsel
Chief Legal Officer, General Counsel
--
--
Ms. Irina Koffler
Ms. Irina Koffler
Investor Relations
Investor Relations
--
--
Dr. David Angulo, M.D.
Dr. David Angulo, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Philippe Tinmouth
Mr. Philippe Tinmouth
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Ivor Macleod, CPA
Mr. Ivor Macleod, CPA
Chief Financial Officer
Chief Financial Officer
71.40K
-30.69%
Mr. Guy Macdonald
Mr. Guy Macdonald
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
55.00K
+71.88%
Mr. Armando Anido
Mr. Armando Anido
Independent Director
Independent Director
48.00K
+92.00%
Dr. Steven C. Gilman, Ph.D.
Dr. Steven C. Gilman, Ph.D.
Independent Director
Independent Director
47.00K
+95.83%
Dr. Ann F. Hanham, Ph.D.
Dr. Ann F. Hanham, Ph.D.
Independent Director
Independent Director
46.62K
+97.37%
Mr. David C. Hastings
Mr. David C. Hastings
Independent Director
Independent Director
46.18K
+99.21%
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月16日 週五
更新時間: 5月16日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Federated Hermes Global Investment Management Corp.
7.42%
Kingdon Capital Management, L.L.C.
5.73%
The Vanguard Group, Inc.
4.25%
Avidity Partners Management LP
3.15%
AMH Equity, Ltd.
1.61%
Other
77.85%
持股股東
持股股東
佔比
Federated Hermes Global Investment Management Corp.
7.42%
Kingdon Capital Management, L.L.C.
5.73%
The Vanguard Group, Inc.
4.25%
Avidity Partners Management LP
3.15%
AMH Equity, Ltd.
1.61%
Other
77.85%
股東類型
持股股東
佔比
Hedge Fund
11.22%
Investment Advisor/Hedge Fund
10.55%
Investment Advisor
8.01%
Individual Investor
2.24%
Research Firm
0.08%
Venture Capital
0.06%
Bank and Trust
0.01%
Other
67.84%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
120
12.60M
32.29%
-2.78M
2025Q1
133
12.41M
31.82%
-4.90M
2024Q4
136
12.64M
33.32%
-10.36M
2024Q3
137
15.37M
41.19%
-4.80M
2024Q2
138
16.05M
43.14%
-5.28M
2024Q1
139
16.82M
45.23%
-5.52M
2023Q4
135
18.46M
50.25%
-3.63M
2023Q3
136
18.83M
51.36%
-3.62M
2023Q2
129
19.59M
54.27%
+67.28K
2023Q1
120
15.56M
46.79%
-1.87M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Federated Hermes Global Investment Management Corp.
2.90M
7.42%
--
--
Mar 31, 2025
Kingdon Capital Management, L.L.C.
2.24M
5.73%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
1.66M
4.25%
-4.84K
-0.29%
Mar 31, 2025
Avidity Partners Management LP
1.23M
3.15%
--
--
Mar 31, 2025
AMH Equity, Ltd.
627.04K
1.61%
+985.00
+0.16%
Mar 31, 2025
Acadian Asset Management LLC
443.06K
1.14%
-24.20K
-5.18%
Mar 31, 2025
Geode Capital Management, L.L.C.
419.49K
1.08%
+14.42K
+3.56%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
416.84K
1.07%
-1.71K
-0.41%
Mar 31, 2025
Bridgeway Capital Management, LLC
353.49K
0.91%
-70.00K
-16.53%
Mar 31, 2025
Angulo (Gonzalez David)
323.28K
0.83%
+23.00K
+7.66%
Apr 09, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
Dimensional US Core Equity 1 ETF
0%
Avantis US Small Cap Equity ETF
佔比0%
iShares Micro-Cap ETF
佔比0%
iShares Core S&P Total U.S. Stock Market ETF
佔比0%
Dimensional US Core Equity 1 ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Jul 16, 2020
Merger
10<1
Jul 16, 2020
Merger
10<1
Jul 16, 2020
Merger
10<1
Jul 16, 2020
Merger
10<1
公告日期
類型
比率
Jul 16, 2020
Merger
10<1
Jul 16, 2020
Merger
10<1
Jul 16, 2020
Merger
10<1
Jul 16, 2020
Merger
10<1
